Improving outcomes for patients with hip osteoarthritis - Hip Injection Trial (HIT)
| Chief Investigator: |
Dr Edward Roddy |
| Principal Investigator: |
Dr Zoe Paskins |
| Study Co-ordinator: |
Dr Andrea Cherrington |
| Funder name / reference number: | National Institute for Health Research; Research For Patient Benefit, (PB-PG-0213-30027) |
| UKCRN Study portfolio: | CPMS: 20242. 163306 |
| Year | 2016 - 2018 |
Study design
Improving outcomes for patients with hip osteoarthritis.
A randomised, clinical, single blind, three-arm, parallel group pragmatic trial with a linked qualitative study.
Primary objective
To compare the longitudinal mean pain scores over 6 months in people with hip osteoarthritis (OA) receiving best current practice alone, with those receiving best current practice plus an ultrasound-guided corticosteroid + local anaesthetic (1% lidocaine hydrochloride)
Interventions
1. Best current treatment only
2. Best current treatment plus an ultrasound-guided intra-articular hip injection of corticosteroid (triamcinolone acetonide 40mg) with 1% lidocaine hydrochloride or
3. Best current treatment plus an ultrasound-guided intra-articular hip injection of 1% lidocaine hydrochloride alone